BongioM., van den beuckenJ.J.J.P., LeeuwenburghS.C.G., and JansenJ.A.Development of bone substitute materials: from “biocompatible” to “instructive.” J Mater Chem, 20, 8747, 2010.
3.
WangW., and YeungK.W.K.Bone grafts and biomaterials substitutes for bone defect repair: a review. Bioactive Mater, 2, 224, 2017.
4.
Bone grafts and substitutes market size, share and trend analysis. Report by material type; by application; by region—Segment forecast, 2021—2028, Polaris Market Research, 2021.
5.
JiangL., ZhengZ., and ZhangM.The incidence of geriatric trauma is increasing and comparison of different scoring tools for the prediction of in-hospital mortality on geriatric patients. World J Emerg Surg, 15, 59, 2020.
6.
FraserA.G., ByrneR.A., KautznerJ., et al.Implementing the new European Regulations on medical devices—clinical responsibilities for evidence-based practice: a report from the Regulatory Affairs Committee of the European Society of Cardiology. Eur Heart J, 41, 2589, 2020.
7.
BurgerE.H., and Klein-NulendJ.Mechanotransduction in bone—role of the lacunocannicular network. FASEB J, 13, 101, 1999.
8.
HadidaM., and MarchatB.Strategy for achieving standardized bone models. Biotechnol Bioeng, 117, 251, 2020.
9.
WillieB.M., YangX., KellyN.H., et al.Cancellous bone osseointegration is enhanced by in vivo loading. Tissue Eng C, 16, 1399, 2010.
10.
GuoJ.L., KimY.S., OrchardE.A., et al.A rabbit femoral condyle defect model for assessment of osteochondral tissue regeneration. Tissue Eng C, 26, 554, 2020.
11.
Ram-LiebigG., BednarzJ., StuerzebecherB., et al.Regulatory challenges for autologous tissue engineered products on their way from bench to bedside in Europe. Adv Drug Deliv Rev, 82–83, 181, 2015.